Danny Noack

ORCID: 0000-0003-1845-7511
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • COVID-19 Clinical Research Studies
  • Viral Infections and Vectors
  • SARS-CoV-2 and COVID-19 Research
  • Mosquito-borne diseases and control
  • Viral Infections and Outbreaks Research
  • Respiratory viral infections research
  • SARS-CoV-2 detection and testing
  • Influenza Virus Research Studies
  • Eicosanoids and Hypertension Pharmacology
  • Fire effects on ecosystems
  • Long-Term Effects of COVID-19
  • HVDC Systems and Fault Protection
  • Venous Thromboembolism Diagnosis and Management
  • Immune cells in cancer
  • Pancreatic and Hepatic Oncology Research
  • Respiratory Support and Mechanisms
  • Dermatological and COVID-19 studies
  • Radiomics and Machine Learning in Medical Imaging
  • Glioma Diagnosis and Treatment
  • COVID-19 and healthcare impacts

Erasmus MC
2019-2025

Erasmus University Rotterdam
2019-2023

Codarts Rotterdam
2023

University Medical Center Utrecht
2022

Icahn School of Medicine at Mount Sinai
2020

Halting transmission The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike (S) glycoprotein binds to host cells and initiates membrane fusion cell infection. This stage in the virus life history is currently a target for drug inhibition. De Vries et al. designed highly stable lipoprotein inhibitors complementary conserved repeat C terminus of S that integrate into membranes inhibit conformational changes necessary fusion. authors tested performance lipoproteins as...

10.1126/science.abf4896 article EN cc-by Science 2021-02-17

Abstract Effective clinical intervention strategies for coronavirus disease 2019 (COVID-19) are urgently needed. Although several trials have evaluated use of convalescent plasma containing virus-neutralizing antibodies, levels neutralizing antibodies usually not assessed and the effectiveness has been proven. We show that hamsters treated prophylactically with a 1:2560 titer human or 1:5260 monoclonal antibody were protected against weight loss, had significant reduction virus replication...

10.1093/infdis/jiab289 article EN other-oa The Journal of Infectious Diseases 2021-05-25

Infections with New World hantaviruses are associated high case fatality rates, and no specific vaccine or treatment options exist. Furthermore, the biology of hantaviral GnGc complex, its antigenicity, fusion machinery poorly understood. Protective monoclonal antibodies against have potential to be developed into therapeutics disease also great tools elucidate glycoprotein complex.

10.1128/mbio.00028-20 article EN mBio 2020-03-24

Morbidity and mortality from influenza are associated with high levels of systemic inflammation. Endothelial cells play a key role in inflammatory responses during severe A virus (IAV) infections, despite being rarely infected humans. How endothelial contribute to is unclear. Here, we developed transwell system which airway organoid–derived differentiated human lung epithelial were co-cultured primary microvascular (LMECs). We compared the susceptibility LMECs pandemic H1N1 recent seasonal...

10.26508/lsa.202201837 article EN cc-by Life Science Alliance 2023-04-18

SARS-CoV-2 attaches to angiotensin-converting enzyme 2 (ACE2) gain entry into cells after which the spike protein is cleaved by transmembrane serine protease (TMPRSS2) facilitate viral-host membrane fusion. ACE2 and TMPRSS2 expression profiles have been analyzed at genomic, transcriptomic, single-cell RNAseq levels. However, transcriptomic data actual validation convey conflicting information regarding distribution of biologically relevant receptor in whole tissues. To describe organ-level...

10.1371/journal.ppat.1010340 article EN cc-by PLoS Pathogens 2022-03-07

Orthohantaviruses are emerging zoonotic viruses that can infect humans via the respiratory tract. There is an unmet need for in vivo model to study infection of different orthohantaviruses physiologically relevant tissue and assess efficacy novel pan-orthohantavirus countermeasures. Here, we describe use a human lung xenograft mouse permissiveness orthohantavirus species its utility preclinical testing therapeutics. Following xenografted tissues, distinct differentially replicated...

10.1371/journal.ppat.1012875 article EN cc-by PLoS Pathogens 2025-01-22

Abstract Containment of the COVID-19 pandemic requires reducing viral transmission. SARS-CoV-2 infection is initiated by membrane fusion between and host cell membranes, mediated spike protein. We have designed a dimeric lipopeptide inhibitor that blocks this critical first step for emerging coronaviruses document it completely prevents in ferrets. Daily intranasal administration to ferrets prevented direct-contact transmission during 24-hour co-housing with infected animals, under stringent...

10.1101/2020.11.04.361154 preprint EN cc-by-nc-nd bioRxiv (Cold Spring Harbor Laboratory) 2020-11-05

Seoul orthohantavirus (SEOV) is a rat-borne zoonotic virus that transmitted via inhalation of aerosolized infectious excreta, and can cause hemorrhagic fever with renal syndrome (HFRS) in humans worldwide. In rats, SEOV predominantly exists as persistent infection the absence overt clinical signs. Lack disease rats attributed to downregulation pro-inflammatory upregulation regulatory host responses. As lung microvascular endothelial cells (LMECs) represent primary target both human...

10.1371/journal.pntd.0012074 article EN cc-by PLoS neglected tropical diseases 2024-03-27

ABSTRACT Effective clinical intervention strategies for COVID-19 are urgently needed. Although several trials have evaluated the use of convalescent plasma containing virus-neutralizing antibodies, effectiveness has not been proven. We show that hamsters treated with a high dose human or monoclonal antibody were protected against weight loss showing reduced pneumonia and pulmonary virus replication compared to control animals. However, ten-fold lower showed no protective effect. Thus,...

10.1101/2020.08.24.264630 preprint EN cc-by-nc-nd bioRxiv (Cold Spring Harbor Laboratory) 2020-08-24
Tessa Noordermeer Roger E. G. Schutgens Chantal Visser Emma Rademaker Moniek P.M. de Maat and 95 more A.J. Gerard Jansen Maarten Limper Olaf L. Cremer Marieke J. H. A. Kruip Henrik Endeman Coen Maas Bas de Laat Rolf T. Urbanus Diederik van de Beek Matthijs C. Brouwer Sanne de Bruin Michiel Coppens Nick van Es T.F. van Haaps Nicole P. Juffermans Mogens Müller Alexander P. J. Vlaar Cees M.P.M. Hertogh Leo Heunks Jacqueline G. Hugtenburg Janine van Kooten Esther J. Nossent Yvo M. Smulders P.R. Tuinman Anton Vonk Noordegraaf Marco J.J.H. Grootenboers Coen van Guldener Matthias Kant A. Lansbergen Joyce Faber G.F. Hajer A. Stemerdink Jeroen van den Akker Ruben Bierings Henrik Endeman Marco Goeijenbier Nicole Hunfeld Eric C. M. Van Gorp Diederik Gommers Marion Koopmans Marieke J.H.A. Kruip Todd Kuiken Thomas Langerak Leebeek Mandy N. Lauw Moniek P.M. de Maat Danny Noack Marthe S. Paats Matthijs P. Raadsen Barry Rockx Casper Rokx Carolina A. M. Schurink Kirby Tong‐Minh Leon van den Toorn Corstiaan A. den Uil Chantal Visser Firdaouss Boutkourt Thirza J. Roest Renée A. Douma Lianne R. de Haan M. ten Wolde Remy H.H. Bemelmans Barbara Festen Susanne Stads Cornelis P. C. de Jager Koen S. Simons M. Louisa Antoni Mettine H.A. Bos J. Burggraaf Suzanne C. Cannegieter Jeroen Eikenboom P.L. den Exter J.J. Miranda Geelhoed M.V. Huisman Evert de Jonge Fleur H.J. Kaptein Frederikus A. Klok Lucia J.M. Kroft Willem M. Lijfering Linda Nab M.K. Ninaber Hein Putter S.R.S. Ramai Andres Rondon Anna H.E. Roukens Milou A.M. Stals Henri H. Versteeg Hubert W. Vliegen B.J.M. van Vlijmen Tove Berg Rainer Brüggemann Bas C. T. van Bussel Hugo Ten Cate Arina J. ten Cate‐Hoek Tilman M. Hackeng

Thrombosis is a frequent and severe complication in patients with coronavirus disease 2019 (COVID-19) admitted to the intensive care unit (ICU). Lupus anticoagulant (LA) strong acquired risk factor for thrombosis various diseases frequently observed COVID-19. Whether LA associated COVID-19 currently unclear.To investigate if critically ill COVID-19.The presence of other antiphospholipid antibodies was assessed ICU. determined dilute Russell's viper venom time (dRVVT) LA-sensitive activated...

10.1002/rth2.12809 article EN cc-by-nc-nd Research and Practice in Thrombosis and Haemostasis 2022-08-01

The Omicron BA.1 (B.1.1.529) SARS-CoV-2 variant is characterized by a high number of mutations in the viral genome, associated with immune escape and increased spread. It remains unclear whether milder COVID-19 disease progression observed after infection humans due to reduced pathogenicity virus or pre-existing immunity from vaccination previous infection. Here, we inoculated hamsters evaluate kinetics shedding, compared Delta (B.1.617.2) animals re-challenged 614G infected showed clinical...

10.1080/22221751.2022.2095932 article EN cc-by Emerging Microbes & Infections 2022-07-05

Puumala orthohantavirus (PUUV) is endemic in Europe and can cause hemorrhagic fever with renal syndrome (nephropathia epidemica). Disease features include fever, thrombocytopenia, acute kidney injury (AKI). This retrospective cohort study of forty PUUV patients aims to characterize associations serum immunological, hemostatic or markers disease severity. While interleukin-18 (IL-18) was significantly increased severely thrombocytopenic (<100 × 109 platelets/L) compared higher platelet...

10.3390/v14071377 article EN cc-by Viruses 2022-06-24

Abstract Orthohantaviruses are emerging zoonotic viruses that can infect humans via the respiratory tract. There is a clear unmet need for an in vivo model to study orthohantavirus infection physiologically relevant tissue and determine broad reactivity of novel countermeasures. Here, we describe use human lung xenograft mouse permissiveness different species assess its utility preclinical testing pan-orthohantavirus therapeutics. Following xenografted tissues, distinct differentially...

10.21203/rs.3.rs-3999668/v1 preprint EN cc-by Research Square (Research Square) 2024-03-06

We studied PUUV infection in high-throughput 3D endothelial vessels-on-chip, that more closely resemble the vivo situation than static 2D cultures. In these vessels, increased monocyte adhesion, but not vascular permeability.

10.1039/d4lc00543k article EN Lab on a Chip 2024-01-01

Abstract SARS-CoV-2 attaches to angiotensin-converting enzyme 2 (ACE2) gain entry into cells after which the spike protein is cleaved by transmembrane serine protease (TMPRRS2) facilitate viral-host membrane fusion. ACE2 and TMPRRS2 expression profiles have been analyzed at genomic, transcriptomic, single-cell RNAseq level, however, biologically relevant receptor organization in whole tissues still poorly understood. To describe organ-level architecture of expression, related ability mediate...

10.1101/2021.03.24.435771 preprint EN cc-by-nc-nd bioRxiv (Cold Spring Harbor Laboratory) 2021-03-24

Abstract The Omicron BA.1 (B.1.1.529) SARS-CoV-2 variant is characterized by a high number of mutations in the viral genome, associated with immune-escape and increased spread. It remains unclear whether milder COVID-19 disease progression observed after infection humans due to reduced pathogenicity virus or pre-existing immunity from vaccination previous infection. Here, we inoculated hamsters evaluate kinetics shedding, compared Delta (B.1.617.2) animals re-challenged 614G infected showed...

10.1101/2022.03.15.484448 preprint EN cc-by-nc-nd bioRxiv (Cold Spring Harbor Laboratory) 2022-03-15

Abstract Morbidity and mortality from influenza are associated with high levels of systemic inflammation. Endothelial cells have been shown to play a key role in this inflammatory response during severe A virus (IAV) infections, despite the fact that these rarely infected humans. However, how endothelial contribute responses is unclear. To investigate this, we developed transwell-system which airway organoid-derived differentiated human lung epithelial at apical side were co-cultured primary...

10.1101/2022.08.19.504520 preprint EN bioRxiv (Cold Spring Harbor Laboratory) 2022-08-19
Coming Soon ...